The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.450
+0.010 (0.29%)
Apr 29, 2026, 9:46 AM EDT - Market open

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
34135023150123714
Upgrade
Market Cap Growth
129.91%1400.09%-84.48%22.52%-82.81%-
Upgrade
Enterprise Value
41042699181139808
Upgrade
Last Close Price
3.443.560.312.041.659.75
Upgrade
PE Ratio
----1805.81-
Upgrade
PS Ratio
0.680.700.060.460.493.52
Upgrade
PB Ratio
--22.286.512.641.006.86
Upgrade
P/TBV Ratio
---4.721.4712.05
Upgrade
EV/Sales Ratio
0.820.850.250.560.553.98
Upgrade
Debt / Equity Ratio
-6.60-6.6034.312.100.880.00
Upgrade
Net Debt / Equity Ratio
-4.46-4.4620.480.650.28-1.10
Upgrade
Net Debt / EBITDA Ratio
-2.41-2.41-1.36-0.68-0.512.71
Upgrade
Net Debt / FCF Ratio
-2.53-2.53-2.42-0.90-0.513.21
Upgrade
Asset Turnover
2.982.982.061.381.091.51
Upgrade
Inventory Turnover
31.6831.6828.6223.0825.5330.05
Upgrade
Quick Ratio
1.311.311.883.623.844.55
Upgrade
Current Ratio
1.591.592.154.134.395.17
Upgrade
Return on Equity (ROE)
---213.36%-92.20%0.13%-16.52%
Upgrade
Return on Assets (ROA)
-13.37%-13.37%-19.67%-15.97%-19.35%-21.08%
Upgrade
Return on Invested Capital (ROIC)
-61.08%-54.86%-70.35%-47.85%-97.58%-377.00%
Upgrade
Return on Capital Employed (ROCE)
-38.50%-38.50%-49.90%-34.50%-31.00%-26.10%
Upgrade
Earnings Yield
-14.80%-17.30%-276.96%-55.21%0.12%-1.53%
Upgrade
FCF Yield
-8.17%-7.93%-129.89%-27.17%-54.80%-4.98%
Upgrade
Buyback Yield / Dilution
-23.11%-23.11%-1.76%8.51%-21.70%-12.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.